Here are five points:
1. The new device is indicated for use in spinal fusion procedures at one or two contiguous levels (L2-S1) in adult patients with degenerative disc disease.
2. NanoMetalene is a sub-micron layer of commercially pure titanium molecularly bonded to a PEEK-OPTIMA polymer from INVIBIO.
3. The device features a variable insertion design and a completely coated graft aperture for autogenous bone graft.
4. The device is a part of SeaSpine’s NanoMetalene family, which includes the Hollywood NanoMetalene, Ventura NanoMetalene and cervical Cambria NanoMetalene interbody devices.
5. SeaSpine plans to launch additional NanoMetalene-coated PEEK interbody devices in the future.
More articles on devices:
Dr. Ronald Lehman 1st in NYC to perform Mazor Robotics’ PROlat procedure: 5 things to know
Amedica submits responses to FDA about CASCADE: 4 notes
Drs. Larry Bankston, Robert Easton perform 1st NUsurface Implant procedure in the South — 5 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
